AIDS treatment
Scope
Date
~
-
Bio & Pharma
Orion to enter dental disease treatment sector
Orion Corp., the Korean company, best known for its signature product choco pie, is entering drug development. Instead of indirectly running a joint...
Nov 30, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion wins trial against Regeneron for US patent lawsuit over biosimilar
South Korean biopharmaceutical company Celltrion Inc. announced Friday that it won its first trial against New York-based biotech giant Regeneron Ph...
Nov 18, 2022 (Gmt+09:00)
-
Waste management
BKT thrives as lone Korean wastewater treatment provider in US
South Korean water treatment provider Bukang Tech(BKT) on Wednesday said it earned a contract to build a wastewater treatment facility in the US sta...
Nov 18, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Biopharma's epilepsy treatment posts impressive growth in US
South Korean SK Biopharmaceuticals' epilepsy treatment Cenobamate has seen rapid growth on the US market.The company on Thursday said the medic...
Nov 11, 2022 (Gmt+09:00)
-
Companies
US water treatment juggernaut Culligan eyes Chungho Nais stake
Culligan, the biggest water treatment company in the United States, is set to become a major shareholder in South Korean water purifier rental firm ...
Nov 09, 2022 (Gmt+09:00)
-
Earnings
Kakao's Q3 profit drops 12% on games, data center construction
South Korea’s mobile platform giant Kakao Corp. announced its third-quarter earnings on Nov. 3, including quarterly operating profit of 150.3 ...
Nov 04, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
Keppel completes Korean waste treatment firm takeover for $530 mn
Singapore-based Keppel Infrastructure completed the acquisition of South Korea’s leading waste management company EMK Co. for 760 billion won ...
Oct 20, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
Korea's LG Chem buys Nasdaq-listed biotech firm AVEO for $566 mn
South Korea’s chemicals giant LG Chem Ltd. announced on Oct. 18 that it will acquire AVEO Pharmaceuticals Inc., a Nasdaq-listed US biotech fir...
Oct 18, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion wins sales approval for biosimilar Vegzelma in Japan
Celltrion Inc. secured Japan’s approval for sales of its cancer treatment biosimilar CT-P16, a move to help the South Korean biopharmaceutical...
Sep 27, 2022 (Gmt+09:00)
-
Shareholder activism
Hanjin Group management rights feud resolved with aid of LX Group
LX Pantos, an LX Group affiliate, has acquired a 3.86% stake in Hanjin KAL Corp., the holding company of Hanjin Group.The LX Group is considered a k...
Aug 29, 2022 (Gmt+09:00)
-
Future mobility
Hyundai Motor Group to invest in fabless startup BOS Semiconductors
Hyundai Motor Group announced on Wednesday that it will invest in Seongnam-based fabless startup BOS Semiconductors, which designs system-on-chip (S...
Aug 25, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion gains sales approval for biosimilar Vegzelma in Europe
Celltrion Healthcare Co., South Korean biopharmaceutical giant Celltrion Inc.'s global marketing affiliate, said on Friday it has obtained the Europ...
Aug 19, 2022 (Gmt+09:00)
-
COVID-19
Ildong mulls seeking COVID-19 pill approval from Korea first
Ildong Pharmaceutical Co., a South Korean drugmaker, considers seeking approval for a COVID-19 anti-viral pill from the country as Japan postponed g...
Jul 22, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Biopharmaceuticals signs epilepsy drug deal with Brazil’s Eurofarma
South Korea’s SK Biopharmaceuticals Co. has signed a deal to license out its technology for Cenobamate, an antiepileptic drug, to Brazil&rsquo...
Jul 15, 2022 (Gmt+09:00)
-
Pension funds
Korean retirement funds, mutual aids struggle with profitability
Some major retirement funds in South Korea are raising interest rates on their members’ savings accounts in line with global central banks&rsq...
Jul 07, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean biotech firms fold COVID-19 therapeutics development businesses
A string of South Korean pharmaceutical and biotech companies are waving the white flag when it comes to developing COVID-19 treatments. As the...
Jul 04, 2022 (Gmt+09:00)
-
Corporate investment
Samsung Eng. to invest in Vietnam for SE Asia water biz
Samsung Engineering Co. agreed to spend $41 million on Vietnam’s largest private water treatment company for the eco-friendly business in Sout...
Jun 30, 2022 (Gmt+09:00)
-
Healthcare
CHA Healthcare buys major Australian fertility center
South Korea’s medical center operator CHA Healthcare Co. said on Monday it has acquired the management rights of Fertility Specialists of West...
Jun 27, 2022 (Gmt+09:00)
-
Energy
Korea to reboot nuclear power sector with orders, aid
South Korea plans to rebuild the nuclear power plant industry hard hit by the previous government’s nuclear energy phasing-out policy by placi...
Jun 22, 2022 (Gmt+09:00)
language -
Corporate bonds
It's time to bet on high-yield bond funds: Barings
High-yield bonds generally create greater yields than other funds, but low-quality bonds are vulnerable to economic downturns and the firms’ c...
Jun 09, 2022 (Gmt+09:00)
-
Bio & Pharma
Medipost acquires Canada’s OmniaBio for CDMO business
Medipost Co., a South Korean biotechnology company, has acquired a 39.6% stake in OmniaBio Inc., a Canada-based cell and gene therapy contract devel...
May 31, 2022 (Gmt+09:00)
-
Webtoons
Kakao to merge US webtoon, web novel platforms
South Korea’s Kakao Entertainment Co. is set to merge Tapas Media Inc. and Radish Fiction Inc., its webtoon and mobile novel platforms in Nort...
May 19, 2022 (Gmt+09:00)
language -
Bio & Pharma
LG Chem receives FDA nod for CUE-102 cancer treatment phase 1 trials
LG Chem Life Sciences, the biopharmaceutical unit of LG Chem Ltd., has received the US Food and Drug Administration’s approval for phase 1 cli...
May 13, 2022 (Gmt+09:00)
-
Sovereign wealth funds
Yoon admin to expand KIC's fund management base
South Korea's new president Yoon Suk-yeol, who took office on Tuesday, is set to push the expansion of sovereign wealth fund Korea Investment Corpor...
May 12, 2022 (Gmt+09:00)
-
Business & Politics
South Korea’s new president offers Pyongyang economic aid for denuclearization
SEOUL—South Korea’s new president said he would keep the door open for dialogue with North Korea and provide support for its fragile econo...
May 11, 2022 (Gmt+09:00)
-
Bio & Pharma
HK inno.N receives sales permit for ulcer treatment in China
HK inno.N is expediting its global expansion with its latest drug K-Cab designed to treat peptic ulcers.The South Korean pharmaceutical company an...
Apr 13, 2022 (Gmt+09:00)
-
Bio & Pharma
FDA to review Hanmi Pharmaceutical’s Rolontis for marketing approval
The US Food and Drug Administration has begun reviewing a medicine developed by South Korea’s Hanmi Pharmaceutical Co. for marketing authoriza...
Apr 13, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
SK Ecoplant buys e-waste recycling firm for $1 bn
South Korea's SK Ecoplant Co. has acquired Singapore-based electronic waste (e-waste) disposal and recycling company TES Envirocorp Pte. Ltd for $1 ...
Feb 21, 2022 (Gmt+09:00)
language -
Korean biotech startup signs license deal with US firm
South Korea's biotech startup Novelty Nobility Inc. has signed a global license agreement for its antibody treatment candidate with a US biopharmace...
Feb 17, 2022 (Gmt+09:00)
-
IPOs
Hyundai Engineering drops IPO plan on stock market weakness
Hyundai Engineering Co., the plant engineering and construction unit of South Korea’s Hyundai Motor Group, dropped a listing plan to raise up ...
Jan 28, 2022 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand